Andersson Ida, Bladh Linda, Mousavi-Jazi Mehrdad, Magnusson Karl-Eric, Lundkvist Ake, Haller Otto, Mirazimi Ali
Center for Microbiological Preparedness/Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden.
J Virol. 2004 Apr;78(8):4323-9. doi: 10.1128/jvi.78.8.4323-4329.2004.
Crimean-Congo hemorrhagic fever virus (CCHFV) belongs to the genus Nairovirus within the family Bunyaviridae and is the causative agent of severe hemorrhagic fever. Despite increasing knowledge about hemorrhagic fever viruses, the factors determining their pathogenicity are still poorly understood. The interferon-induced MxA protein has been shown to have an inhibitory effect on several members of the Bunyaviridae family, but the effect of MxA against CCHFV has not previously been studied. Here, we report that human MxA has antiviral activity against CCHFV. The yield of progeny virus in cells constitutively expressing MxA was reduced up to 1,000-fold compared with control cells, and accumulation of viral genomes was blocked. Confocal microscopy revealed that MxA colocalizes with the nucleocapsid protein (NP) of CCHFV in the perinuclear regions of infected cells. Furthermore, we found that MxA interacted with NP by using a coimmunoprecipitation assay. We also found that an amino acid substitution (E645R) within the C-terminal domain of MxA resulted in a loss of MxA antiviral activity and, concomitantly, in the capacity to interact with CCHFV NP. These results suggest that MxA, by interacting with a component of the nucleocapsid, prevents replication of CCHFV viral RNA and thereby inhibits the production of new infectious virus particles.
克里米亚-刚果出血热病毒(CCHFV)属于布尼亚病毒科内的内罗病毒属,是严重出血热的病原体。尽管人们对出血热病毒的了解不断增加,但决定其致病性的因素仍知之甚少。干扰素诱导的MxA蛋白已被证明对布尼亚病毒科的几个成员有抑制作用,但此前尚未研究过MxA对CCHFV的作用。在此,我们报告人类MxA对CCHFV具有抗病毒活性。与对照细胞相比,组成性表达MxA的细胞中子代病毒的产量降低了多达1000倍,并且病毒基因组的积累被阻断。共聚焦显微镜显示,MxA与CCHFV的核衣壳蛋白(NP)在受感染细胞的核周区域共定位。此外,我们通过免疫共沉淀试验发现MxA与NP相互作用。我们还发现,MxA C末端结构域内的一个氨基酸取代(E645R)导致MxA抗病毒活性丧失,并同时导致其与CCHFV NP相互作用的能力丧失。这些结果表明,MxA通过与核衣壳的一个成分相互作用,阻止CCHFV病毒RNA的复制,从而抑制新的感染性病毒颗粒的产生。